Outcome Following Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Stokes, J. B. [1 ]
Walters, D. M. [1 ]
Norris, N. J. [1 ]
Stelow, E. B. [1 ]
Rich, T. A. [1 ]
Weiss, G. R. [1 ]
De Lange, E. E. [1 ]
Adams, R. B. [1 ]
Bauer, T. W. [1 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2009年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
    Mikulic, Danko
    Mrzljak, Anna
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (20) : 5398 - 5407
  • [22] Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer
    Kharofa, Jordan
    Tsai, Susan
    Kelly, Tracy
    Wood, Clint
    George, Ben
    Ritch, Paul
    Wiebe, Lauren
    Christians, Kathleen
    Evans, Douglas B.
    Erickson, Beth
    RADIOTHERAPY AND ONCOLOGY, 2014, 113 (01) : 41 - 46
  • [23] Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
    Massani, Marco
    Stecca, Tommaso
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Janssen, Quisette P.
    O'Reilly, Eileen M.
    Van Eijck, Casper H. J.
    Groot Koerkamp, Bas
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [25] Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer
    Scheufele, F.
    Friess, H.
    CHIRURG, 2020, 91 (05): : 391 - 395
  • [26] Borderline Resectable Pancreatic Cancer Patients Have Superior Survival Following Neoadjuvant Therapy Compared to Upfront Resectable Patients
    Deig, C.
    Trone, K.
    Beneville, B.
    Stratton, A.
    Liu, A.
    Kanwar, A.
    Grossblatt-Wait, A.
    Sheppard, B.
    Attia, F.
    Bassale, S.
    Chen, Y.
    Keith, D.
    Chen, E.
    Lopez, C.
    Gilbert, E.
    Billingsley, K.
    Nabavizadeh, N.
    Thomas, C. R., Jr.
    Grossberg, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E581 - E582
  • [27] Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma
    Reza, Joseph Arturo
    Monreal, Alberto
    Meyer, Patrick Hunter
    Patel, Swati
    Zakari, Ahmed
    de la Fuente, Sebastian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [28] Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy
    Javed, Ammar A.
    Wright, Michael J.
    Siddique, Ayat
    Blair, Alex B.
    Ding, Ding
    Burkhart, Richard A.
    Makary, Martin
    Cameron, John L.
    Narang, Amol
    Herman, Joseph
    Zheng, Lei
    Laheru, Daniel
    Weiss, Matthew J.
    Wolfgang, Christopher
    He, Jin
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (01) : 112 - 121
  • [29] Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy
    Ammar A. Javed
    Michael J. Wright
    Ayat Siddique
    Alex B. Blair
    Ding Ding
    Richard A. Burkhart
    Martin Makary
    John L. Cameron
    Amol Narang
    Joseph Herman
    Lei Zheng
    Daniel Laheru
    Matthew J. Weiss
    Christopher Wolfgang
    Jin He
    Journal of Gastrointestinal Surgery, 2019, 23 : 112 - 121
  • [30] OUTCOME OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER IN THE CONTEMPORARY ERA OF NEOADJUVANT CHEMOTHERAPY
    Javed, Ammar A.
    Siddique, Ayat
    Blair, Alex
    Parish, Lindsay
    Burkhart, Richard
    Weiss, Matthew J.
    Cameron, John
    Narang, Amol
    Zheng, Lei
    Laheru, Daniel
    Wolfgang, Christopher L.
    He, Jin
    GASTROENTEROLOGY, 2018, 154 (06) : S1265 - S1265
12345